Back

First in human experience with direct sodium removal using a zero sodium peritoneal solution: a new candidate therapy for volume overload

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Late breaking trial III - Innovative and device therapy Treatment HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Jeffrey Testani

Yale School of Medicine, New Haven (United States of America)

11 More presentations in this session

Presentation thumbnail
Reduction of Mitral Regurgitation in Patients with Heart Failure and Secondary Mitral Regurgitation: Relationship Between Baseline Biomarkers and Outcomes from the COAPT Trial
Professor W. Abraham (Columbus, US)
Slides Video
Presentation thumbnail
Discussion - COAPT.
Video
Presentation thumbnail
A first in human multi-center, open label, prospective study to evaluate the safety, usability and performance of the V-LAP system
Professor W. Abraham (Columbus, US)
Slides
Presentation thumbnail
Discussion - A first in human multi-center, open label, prospective study to evaluate the safety, usability and performance of the V-LAP system.
Video
Presentation thumbnail
Cardiac contractility modulation (CCM) in HFrEF NYHA Class III patients
Professor D. Burkhoff (New York, US)
Slides Video

Access the full session

Session thumbnail
Late breaking trial III - Innovative and device therapy

The Event

Event poster

Heart Failure 2019

25 May - 28 May 2019
You may be interested in
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
Expert panel discussion and Q&A

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources